These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 2461252)
1. Cytotoxic effects of anti-CD5 radioimmunotoxins on human tumors in vitro and in a nude mouse model. Manske JM; Buchsbaum DJ; Hanna DE; Vallera DA Cancer Res; 1988 Dec; 48(24 Pt 1):7107-14. PubMed ID: 2461252 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model. Weil-Hillman G; Runge W; Jansen FK; Vallera DA Cancer Res; 1985 Mar; 45(3):1328-36. PubMed ID: 3971376 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia. Fishwild DM; Aberle S; Bernhard SL; Kung AH Cancer Res; 1992 Jun; 52(11):3056-62. PubMed ID: 1375534 [TBL] [Abstract][Full Text] [Related]
4. The role of ricin B chain in the intracellular trafficking of anti-CD5 immunotoxins. Manske JM; Buchsbaum DJ; Vallera DA J Immunol; 1989 Mar; 142(5):1755-66. PubMed ID: 2465347 [TBL] [Abstract][Full Text] [Related]
5. Human leukemia cell binding and killing by anti-CD5 radioimmunotoxins. Buchsbaum DJ; Nelson LA; Hanna DE; Vallera DA Int J Radiat Oncol Biol Phys; 1987 Nov; 13(11):1701-12. PubMed ID: 3499427 [TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of L6-ricin immunotoxin against the H2981-T3 lung adenocarcinoma cell line in vitro and in vivo. Schmidberger H; King L; Lasky LC; Vallera DA Cancer Res; 1990 Jun; 50(11):3249-56. PubMed ID: 1692258 [TBL] [Abstract][Full Text] [Related]
7. Efficient transplantation of human non-T-leukemia cells into nude mice and induction of complete regression of the transplanted distinct tumors by ricin A-chain conjugates of monoclonal antibodies SN5 and SN6. Hara H; Luo Y; Haruta Y; Seon BK Cancer Res; 1988 Aug; 48(16):4673-80. PubMed ID: 2969282 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain. Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451 [TBL] [Abstract][Full Text] [Related]
9. Antigenic modulation by anti-CD5 immunotoxins. Manske JM; Buchsbaum DJ; Azemove SM; Hanna DE; Vallera DA J Immunol; 1986 Jun; 136(12):4721-8. PubMed ID: 3086441 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of human T-cell tumor growth by T101-ricin A-chain in an athymic mouse model. Leonard JE; Johnson DE; Shawler DL; Dillman RO Cancer Res; 1988 Sep; 48(17):4862-7. PubMed ID: 3261627 [TBL] [Abstract][Full Text] [Related]
11. [Selective elimination of human T-leukemia cells with the use of a conjugate of the A-chain of ricin and a monoclonal antibody against CD5-antigen of T-lymphocytes]. Tonevitskiĭ AG; Toptygin AIu; Marks U; Filatov AV; Alekseev LP Dokl Akad Nauk SSSR; 1989; 307(6):1507-11. PubMed ID: 2480212 [No Abstract] [Full Text] [Related]
12. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2. Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821 [TBL] [Abstract][Full Text] [Related]
13. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors. Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356 [TBL] [Abstract][Full Text] [Related]
14. Combined immunochemotherapy of human solid tumors in nude mice. Weil-Hillman G; Uckun FM; Manske JM; Vallera DA Cancer Res; 1987 Jan; 47(2):579-85. PubMed ID: 3491678 [TBL] [Abstract][Full Text] [Related]
15. Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models. Shah SA; Halloran PM; Ferris CA; Levine BA; Bourret LA; Goldmacher VS; Blättler WA Cancer Res; 1993 Mar; 53(6):1360-7. PubMed ID: 7680284 [TBL] [Abstract][Full Text] [Related]
16. Parameters affecting tumor-specific delivery of anti-CD5 antibody-ricin A chain immunotoxins in vivo. Rostaing-Capaillon O; Casellas P Cancer Res; 1990 May; 50(10):2909-16. PubMed ID: 1692250 [TBL] [Abstract][Full Text] [Related]
17. Immunotoxins to a human melanoma-associated antigen: comparison of gelonin with ricin and other A chain conjugates. Sivam G; Pearson JW; Bohn W; Oldham RK; Sadoff JC; Morgan AC Cancer Res; 1987 Jun; 47(12):3169-73. PubMed ID: 3495329 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins. Derocq JM; Casellas P; Laurent G; Ravel S; Vidal H; Jansen F J Immunol; 1988 Oct; 141(8):2837-43. PubMed ID: 3262669 [TBL] [Abstract][Full Text] [Related]
19. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain. Ramakrishnan S; Houston LL Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A-chain immunotoxins on murine liver parenchymal cells. Blakey DC; Skilleter DN; Price RJ; Watson GJ; Hart LI; Newell DR; Thorpe PE Cancer Res; 1988 Dec; 48(24 Pt 1):7072-8. PubMed ID: 3263899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]